Lol. AMRN will be FDA approved for ANCHOR meaning insurance reimbursement (Lovaza was denied) and while Lovaza did okay in ANCHOR, they barely scratched the surface. Better results, inflammation markers, and without the fish smells, burps, farts, indigestion, etc. Vascepa snipes their customers AND expands the market. Thanks for doing some of the lifting, Lovaza!